Partner content
Break down barriers to save lives
The UK must cut through bureaucracy if it is to remain a leader in life sciences.
BySponsored
Partner content
Now is the time to move from pilot to practice
To realise its Ten-Year Health Plan, the NHS must focus on digital adoption, not just innovation.
By
Partner content
Uk Lung Cancer 20 years on: What’s next?
A special supplement, sponsored by the UK Lung Cancer Coalition, looking at how Britain can make progess in its battle…
Partner content
Podiatry’s pivotal role
The practice will be key in delivering the NHS’s ten-year plan.
By
Partner content
Fit for the future or stuck in the past?
Type 1 diabetes screening is testing the government’s health ambitions.
By
Partner content
Prevention is better than cure – but are we there yet?
Consistent policy frameworks, timelines and accountability are needed to shift to a healthier food system and turn the tide on…
By
Partner content
Kidney care is a quiet test of NHS reform
Fixing the system is vital for the thousands of patients across the UK living with renal conditions
Partner content
Why prescription charges for IBD must end
The NHS can reduce hospital admissions and shift focus from sickness to prevention.
By
Partner content
Celebrate with an “Ocean State of Mind” this festive season
Explora Journeys is offering Caribbean itineraries on its brand new ships, with ocean-front suites, fine culinary experiences and a focus…
Partner content
The UK’s mRNA opportunity: Growth, resilience, leadership
A special supplement, sponsored by Moderna, looking at how the UK can leverage mRNA to turbocharge its life sciences sector…
By
Partner content
The UK is positioning itself as a hub for mRNA science and innovation
The countries that lead in life sciences will be those that translate scientific excellence into population impact.
By
Partner content
How can mRNA become the UK’s next strategic growth engine?
From cancer and respiratory illnesses to rare diseases, mRNA offers promise. Can Britain turn it into an economic superpower?
Partner content
The need for deep and lasting life science partnerships
The government is on a mission to make sure the next great health breakthroughs happen, and are commercialised, in the…
By
Partner content
The value of vaccinations
Beyond being a public health intervention, vaccinations strengthen communities and help grow the economy.
By
Partner content
Infographic: Moderna’s strategic partnership with the UK government
A look at the numbers behind a ten-year partnership aiming to boost the UK’s health resilience, its life sciences sector,…
Partner content
An investment in jobs, skills, and industrial capacity
This model of collaboration between government and business will anchor Britain as a global hub of innovation.
By
Partner content
An investment in the future
Moderna’s ten-year partnership with the UK government hopes to position the country at the cutting edge of mRNA technology.
Partner content
A flagship for vaccine innovation
The MITC aspires to boost UK pandemic readiness, global trials, and the next generation of scientific talent.
Partner content
Long-term health conditions: Inflammatory bowel disease
A special supplement, sponsored by Takeda and Crohn’s & Colitis UK, looking at how the UK can better serve those…
By
Partner content
Promote visibility to close sport’s gender gap
Tax relief on the production cost of women’s sports coverage would help bring down a big barrier to female participation.
By